within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BA03_Heparin;

model Heparin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.5555555555555556e-06,
    adminDuration = 600,
    adminMass = 5000 / 1000000,
    adminCount = 1,
    Vd = 5.9999999999999995e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Heparin</td></tr><tr><td>ATC code:</td><td>C05BA03</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>5000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.06</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.08</td><td>L/kg/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Heparin is an anticoagulant used to prevent and treat blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and during surgery or dialysis. It is an approved drug widely used in clinical practice for its rapid onset of action by parenteral routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for adult patients (general population) following intravenous bolus administration.</p><h4>References</h4><ol><li><p>Izadpanah, M, et al., &amp; Mohammadi, M (2015). Heparin and related drugs for venous thromboembolism prophylaxis: subcutaneous or intravenous continuous infusion?. <i>Journal of comparative effectiveness research</i> 4(2) 167–184. DOI:<a href=\"https://doi.org/10.2217/cer.14.78\">10.2217/cer.14.78</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25825845/\">https://pubmed.ncbi.nlm.nih.gov/25825845</a></p></li><li><p>Moffett, BS, et al., &amp; Yee, DL (2017). Population pharmacokinetics of human antithrombin concentrate in paediatric patients. <i>British journal of clinical pharmacology</i> 83(11) 2450–2457. DOI:<a href=\"https://doi.org/10.1111/bcp.13359\">10.1111/bcp.13359</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28664670/\">https://pubmed.ncbi.nlm.nih.gov/28664670</a></p></li><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=\"https://doi.org/10.1186/s13054-016-1208-6\">10.1186/s13054-016-1208-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27885969/\">https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C05BA03 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Heparin;
